Background This single-institution, consecutive series of transsphenoidal procedures included all patients in a defined population of 2.6 million inhabitants who underwent surgery during a specific time period. Objective We sought to determine the surgical complication rate and overall survival rate after transsphenoidal surgery for pituitary adenoma. Methods All transsphenoidal procedures for histologically verified pituitary adenomas performed between September 2002 and February 2011 at our institution were included in this study. The data were obtained from a prospectively collected database and from reviewing medical records. No patients were lost to follow-up, and the median follow-up time was 28 months. Results A total of 506 transsphenoidal procedures were performed on 446 patients. There were 268 microscopic and 238 endoscopic procedures involving 352 non-functioning and 154 hormone-secreting adenomas. A total of 73 % of the procedures were primary surgeries, and 27 % were repeat surgeries for tumor recurrence. The overall complication rate was 9.1 %. The three most frequent complications were cerebrospinal fluid (CSF) leakage (4.7 %), meningitis (2 %), and visual deterioration (2 %). Multivariate analyses showed that the overall risk for complications increased with older age, surgery for recurrent tumors, and surgery performed by a low-volume surgeon. There was no significant difference in the overall complication rate between the microsurgical and endoscopic techniques. The rate of surgical mortality was 0.6 %, and the overall survival rates at 1 and 5 years were 95 % and 90 %, respectively. The only negative predictor of survival was older age. Conclusions Transsphenoidal surgery for pituitary adenomas has a low complication rate and a low rate of mortality. We did not find a significant difference in the complication rate between endoscopic and microscopic techniques.
Introduction
Pituitary adenomas constitute approximately 10 % of all primary intracranial tumors [39] . These tumors are classified according to hormonal activity (non-secreting, prolactinoma, or adrenocorticotropic hormone [ACTH]-, growth hormone [GH]-or thyroid stimulating hormone [TSH]-producing) [26] . Surgery is the treatment of choice for most patients, although for prolactinomas the treatment of choice is medical, often with dopamine agonists.
Surgery may be an option in prolactinomas if the patient experiences unacceptable side effects from the medication, or if the patient has a strong desire for surgery.
The preferred approach is either microscopic or endoscopic transsphenoidal surgery. At our institution, the endoscopic transsphenoidal technique for pituitary adenoma surgery was introduced in 2005 and has since gradually replaced transsphenoidal microsurgery. The purpose of adopting a new surgical technique is to accomplish less invasive, more radical surgery with fewer complications. Hence, it is essential for all surgeons and departments to review their complication and success rates when a new surgical technique is implemented.
It is generally recognized that radical surgery is not achieved in the majority of patients with pituitary adenomas, and that approximately 15-20 % of patients require repeat surgery because of tumor recurrence [2, 31] . The fact that many patients harbor remnants of tumors is also demonstrated by the relatively low cure rates for hormone-secreting adenomas, ranging from 15-50 % for GH-producing macroadenomas to 34 % for ACTH-producing macroadenomas [8, 15, 42] . Despite having tumor remnants or experiencing repeat surgery, the quality of life for many patients can be relatively good [32, 35] . Thus, striving for radicality must be carefully balanced against the risk and ramifications of surgical morbidity.
The aim of this study was to determine the complication rate and the overall survival rate after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma. Most previous studies comparing the two techniques have included patients treated by a single surgeon or team [5, 37] . Norway is well-suited for population-based epidemiological studies because of the country's stable population and public healthcare system. This single-institution, consecutive series of transsphenoidal procedures included all patients in a defined population of 2.6 million inhabitants who underwent surgery during a specific time period.
Methods and materials

Study design
A total of 506 consecutive, transsphenoidal procedures (446 patients) performed between September 2002 and February 2011 were included in this retrospective study. All procedures were performed at the Oslo University Hospital (OUH)-affiliated hospitals, Rikshospitalet and Ullevål. The data were retrieved from a prospectively collected database of all tumor surgeries performed at our institution and from reviewing medical records. Only histologically verified pituitary adenomas were included. Patient vital status (alive or deceased) and time of death were obtained from the Norwegian Population Registry (Folkeregisteret) on November 5, 2011.
Recorded variables
The following patient characteristics were recorded: the age (at surgery), gender, adenoma type (non-secreting or GH-, ACTH-, TSH-or prolactin-producing), tumor size (microadenoma (<10 mm) or macroadenoma (≥10 mm)), preoperative visual deficit, preoperative hormone substitution (glucocorticoid, thyroxin, growth hormone, gonadotropins or antidiuretic hormone (ADH)), number of previous surgeries for pituitary adenoma, primary surgery or reoperation, vital statistics, and time of death.
The following postoperative complications were recorded: visual deterioration, neurological deterioration other than visual deterioration, cerebrospinal fluid (CSF) leakage requiring lumbar drainage or surgical repair, reoperation for hematoma, meningitis (requiring antibiotics for ≥7 days, positive bacterial cultures not necessary), carotid artery injury, and deep vein thrombosis (DVT)/pulmonary embolism (PE).
Furthermore, the hospital (Rikshospitalet or Ullevål), surgical technique (microsurgical or endoscopic) and number of surgical procedures per surgeon were recorded. The surgeons were divided into two units for comparison. One unit consisted of the most experienced pituitary surgeon at our institution (high-volume surgeon), and the other unit comprised the remaining surgeons (low-volume surgeons).
Surgical technique
All patients underwent general anesthesia. In most cases, total intravenous anesthesia (TIVA) was used. Before 2005/2006, the standard microsurgical endonasal transseptal approach was used. The right nostril was entered, an incision was made in the anterior part of the septum, and a dissection of the mucosa from the septal cartilage and bone was performed. The anterior wall of the sphenoid sinus was opened bilaterally, and any septum in the sphenoid was removed, as necessary. The floor of the sella was opened with a high-speed drill, and the tumor was removed with standard instruments, such as curettes, dissectors, suction and micro forceps. After tumor removal, the floor of the sella was reconstructed in most cases. The materials and techniques used for the floor reconstruction depended on the intraoperative findings and the surgeon's preference. In pediatric patients with small nostrils, a sublabial approach was used. All patients had nasal packing that was removed on the first postoperative day.
Beginning in 2005, the endoscopic endonasal transsphenoidal approach was gradually introduced. One or both nostrils were entered, depending on the space available and the need for exposure during surgery. Standard Storz endoscopes (180/4 mm) with 0°, 30°and 45°angulations (attached to cameras) were used. In the later period of the study, the endoscopes were attached to high-definition (HD) cameras. Based on personal preference, some surgeons used a fixed-endoscope support, whereas others did not. The middle turbinate was lateralized to improve access to the sphenoethmoid recess and the sphenoid ostium, which were identified and enlarged to allow the passage of the endoscope and surgical instruments. Septa in the sphenoid sinus were removed as necessary. Tumor resection was performed with standard surgical instruments, such as curettes, dissectors, suction and micro forceps, depending on the tumor size and firmness. In tumors with parasellar extensions, an ultrasonic Doppler probe was used to localize the internal carotid artery. As a result of the broader view that was possible with the endoscope, the opening of the sella was extended, which made the closure of the sella floor more challenging. Sella floor reconstruction was most often performed in a multilayer fashion with different autologous and artificial materials. A vascularized nasal septal flap was also used as needed.
All patients were given 2 g of cephalothin at the beginning of surgery for infection prophylaxis. In patients with suspected hypersensitivity to cephalothin, 600 mg of clindamycin was used instead. All patients, except for a few with Cushing's disease, were given an intraoperative intravenous (IV) infusion of 12 mg/h hydrocortisone (Solu-Cortef®) until 8 am on the first postoperative day. Thereafter, cortisone was administered orally, starting with 50 mg x 4 and tapering over a 7-day period to a maintenance dose of 12.5 mg x 2. The patients were maintained on this dose until a scheduled 3-month postoperative follow-up in the department of endocrinology. Cushing's disease patients were not prescribed any postoperative steroids unless they showed clinical symptoms of hypocortisolism or serum cortisol values <100 μmol/ L. The patients were mobilized and prescribed low molecular-weight heparin subcutaneously, beginning on the first postoperative day.
Follow-up
All patients had scheduled 3-month follow-ups that included magnetic resonance imaging (MRI) scans and ophthalmologic evaluations at the referring department of endocrinology. Thereafter, most patients had follow-ups every 6 months. As necessary, the patients were discussed in a multidisciplinary, pituitary-related meeting or observed in a neuroendocrine outpatient ward, and consulted with both an endocrinologist and a neurosurgeon in the same session.
Statistical analysis
Standardized statistical analyses were performed with Student's t-test to identify between-group differences. We used univariate and multivariate Cox and logistic regression analyses after ascertaining that the assumptions of these models were fulfilled.
Survival curves were generated using the Kaplan-Meier estimator. The log-rank test was used to compare different survival curves. Survival curves for the general population were created using life tables from Statistics Norway (www. statbank.ssb.no), which were matched by age, cohort, and gender. A p-value <0.05 was considered significant. R v 2. 15 was used for the statistical analyses.
The data protection official at OUH approved this study.
Results
This single-institution, consecutive series consisted of 506 transsphenoidal procedures (446 patients) performed between September 2002 and February 2011. The patient characteristics are shown in Table 1 . The median patient age at the time of surgery was 57 years (range 9-85 years). Of the adenomas, there were 79 GH-secreting, 51 ACTH-secreting, 20 prolactinsecreting, four TSH-secreting and 352 non-secreting. In total, 88.9 % were macroadenomas. The microscopic technique was used in 268 (53 %) cases, and the endoscopic technique was used in 238 (47 %) cases. Endoscopy-assisted microsurgery was included in the microscopy group. A total of 73 % of the surgeries were primary, and 27 % were repeat surgeries for tumor recurrence. Of the patients undergoing repeat surgery, 103 had a second operation, 22 had a third, nine had a fourth, two had a fifth, and one patient had a sixth and seventh. No patients were lost to follow-up (median follow-up 28 months, range 3-103 months). Table 3 . The multivariate analyses revealed that the overall risk for complications increased with older age, surgery for recurrent tumors, and surgery performed by low-volume surgeons.
There was no significant difference in the overall complication rate between the microsurgical and the endoscopic techniques, although there was a tendency toward a higher complication rate in the endoscopy group (Table 4) .
CSF leakage
Postoperative CSF leakage occurred after 24 (4.7 %) procedures and was the most frequent complication. The CSF treatment was either lumbar drainage, surgical exploration and repair or both. CSF leakage occurred significantly more frequently after recurrent tumor surgeries than after primary surgery (p=0.04) and also after surgeries performed by lowvolume surgeons (p=0.02). There was no significant difference in the CSF leakage rate between the endoscopic and microscopic transsphenoidal surgeries (p=0.30).
Meningitis
Meningitis was the second most frequent complication. There were 10 cases (2 %), all successfully treated with antibiotics. In half of these cases, there was concurrent CSF leakage. Meningitis was significantly more frequent following endoscopic surgery than microsurgery (p=0.042), and there was also a significantly higher rate of meningitis following surgery performed by a low-volume surgeon (p=0.01). There was a slight difference (not statistically significant) in the occurrence of meningitis between primary and recurrent surgeries (p=0.08).
Neurological deterioration
In total, 46 % of the procedures were performed on patients with visual deficits prior to surgery. Nine procedures (2 %) caused visual deterioration because of either intraoperative manipulation of the optic chiasm or nerve (n=6) or a postoperative hematoma compressing the optic pathways (n=3). Five procedures (1 %) resulted in new neurological postoperative deficits other than visual deterioration. One patient acquired a hemiparesis secondary to carotid artery injury, one displayed diffuse neurological impairment caused by cerebral infarction, two showed signs of ophthalmoplegia, and one developed anosmia.
Vascular complications
Six patients required reoperation for hematomas. Two patients sustained injury to the internal carotid artery during surgery, and four suffered from postoperative DVT/PE. The 12 patients with vascular complications had macroadenomas.
Surgical mortality
The surgical mortality rate, which was defined as death within 30 days of surgery, was 0.6 % (three patients). Two patients with large macroadenomas died from massive PEs 15 and 25 days post-surgery. The third patient was moribund prior to surgery because of pituitary apoplexy and died 12 days postoperatively from generalized cerebral edema.
Survival
The overall survival rates at 1 and 5 years were 95 % and 90 %, respectively, which were significantly lower than for the age-, gender-and cohort-adjusted control population (Fig. 1) . Univariate and multivariate analyses of the potential factors predicting less favorable survival are presented in Table 5 
Discussion
This study was performed to determine the complication rate and overall survival rate after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma. The overall surgical complication rate was 9.1 %; CSF leakage (4.7 %), meningitis (2 %), and visual deterioration (2 %) were the most frequent complications. There was no significant difference in the overall complication rate between the microsurgical and endoscopic techniques. The overall survival rates at 1 and 5 years were 95 % and 90 %, respectively, which were significantly lower than for the age-, gender-and cohortadjusted control population. 
Overall complication rate
The overall complication rate of 9.1 % corresponds well to other published rates [22, 27] . Multivariate analyses showed an increased overall risk for complications with increasing age, surgery for recurrent tumors, and surgery performed by lowvolume surgeons. The overall complication rate has previously been shown to be dependent on several different factors, such as the anatomical localization, firmness, and size of the tumor, the extent of the removal, occurrence of prior surgery, and radiotherapy [21, 29] . In a microsurgical series, the overall complication rate has been reported to be in the ranges of 8.2-47 % [7, 36, 45] and 10-26.3 % using the endoscopic technique [5, 12, 16, 23] . Obviously, these rates are contingent on the authors' definitions of a complication. For instance, in this study, we did not include endocrinological and nasal complications.
Postoperative CSF leakage
The most frequent complication associated with transsphenoidal surgery in our series was CSF leakage, with a rate of 4.7 %. Significant risk factors for CSF leakage were surgery for recurrent tumors and surgery performed by a lowvolume surgeon. There was no significant difference in the CSF leakage rate between endoscopic and microscopic surgery. Other studies have reported leakage rates between 0.5 and 6.0 % [4, 23, 25, 26, 46] . The lowest rates are from studies in which the procedures were performed by only a single surgeon. The risk of CSF leakage is reportedly higher in macroadenomas than in microadenomas [4, 20] . Our series contained a high proportion of macroadenomas (89 %), which may have contributed to the relatively high incidence of CSF leakage. A recent publication showed that an increased body mass index is an independent predictor of postoperative CSF leakage after endoscopic transsphenoidal surgery [14] .
Meningitis
The second most frequent complication, meningitis, was observed in 10 cases (2 %). Published data have shown an incidence of meningitis between 0.4 and 2.19 %, which seems to be closely correlated with the incidence of CSF leakage [5, 10, 12, 16, 23, 30, 34] . Half of our patients with meningitis had concurrent CSF leakage. Risk factors for meningitis were endoscopic surgery and surgery performed by a low-volume surgeon. Thus, meticulous closure and reconstruction of the skull base appear to be the most important measures to prevent postoperative meningitis.
Neurological deterioration
Nine procedures were followed by visual deterioration (1.8 %). Mechanical injury to the optic nerves and chiasm is a well-known complication that can be caused by trauma, hemorrhage, or ischemia [40] . A large proportion of our patients had preoperative visual field deficits because of large tumors with suprasellar extension, making the patients vulnerable to additional optic nerve dysfunction. Other surgeryrelated neurological injuries were rare, totaling five procedures (1 %) in this study. These injuries can be caused by pressure on the cranial nerves, vascular occlusion, or effects on the hypothalamus or brainstem. Complications related to surgical method During the study period, a new surgical method using the endoscopic endonasal technique for transsphenoidal surgery was introduced. There was no significant difference in the overall complication rate between the new endoscopic approach and the traditional microscopic method. Three metaanalyses comparing the two surgical methods have recently been published; these studies have shown lower complication rates for endoscopic surgery than for microscopic surgery [13, 19, 33] . By including all patients who underwent surgery with the new endoscopic technique, the problems connected to the learning curve were simultaneously incorporated. Thus, as more experience is gained, one can anticipate a further decrease in the number of complications. The objective of implementing this new surgical technique was, as mentioned above, to accomplish more radical but less invasive surgery with fewer complications; only time will tell if these goals can be achieved.
Complications related to surgeons' experience
Multivariate analyses show an increased overall risk of complications with surgery performed by low-volume surgeons, which has also been demonstrated previously [3] . A total of 15 different surgeons served as main surgeon, and 10 surgeons performed less than five procedures each in this series. There are two reasons for this: first, that some of these surgeries were performed as emergency surgeries when more experienced surgeons were not available, and second, that some of the procedures were performed with an experienced surgeon as a second surgeon. Other studies of the endoscopic technique have revealed decreased complications in conjunction with increased surgeon experience [5, 11, 16, 24] . Similarly, experience increases the cure rate for hormone-secreting tumors [1, 9] . Clayton and coworkers have stated that a pituitary center should serve a population of 5 million people at a minimum and be managed by only two surgeons to ensure the proper quality of treatment. This aim for centralization, however, must be balanced with the ability to offer 24-hour service throughout a wide and sparsely-populated country, such as Norway, with 5 million inhabitants.
Complications related to primary or recurrent surgery Surgery for recurrent tumors was an independent risk factor for surgery-related complications, corroborating other series that have reported surgical complication rates (after repeat surgery) up to 50 % [43, 44] . This high complication rate might occur because the delicate anatomical layers that can be used as dissection planes in primary surgery are destroyed and invaded by fibrous tissue [6] ; in our experience, the tumor may be more fibrous and firmer during repeat surgery.
Complications related to tumor size Unexpectedly, no difference in the rate of surgical complications between macroadenomas and microadenomas was found. Tumor volume is a strong predictor of complication risks and outcomes for large and giant pituitary adenomas [21, 28] . However, giant tumors that are soft in consistency, located in the midline, and noninvasive may be easily removed, whereas small, fibrous, and laterally located tumors with invasive growth may present a great challenge [17] .
Surgical mortality
The surgical mortality in our series was 0.6 % (three patients).
There are few systematic reviews on surgical mortality from transsphenoidal surgery for pituitary adenomas. Most of the available data are from relatively small, uncontrolled case series from a single center that were performed by one surgeon. However, a systematic meta-analysis of publications examining transsphenoidal surgery for non-functioning pituitary adenomas, including one with 1232 patients, revealed a surgical mortality of 1 % [27] . In the largest pituitary surgery series published to date, Laws et al. observed a 1.05 % surgical mortality rate [25] . In a recently published series of 301 adenomas operated on using the endoscopic endonasal technique, the surgical mortality rate was 1 % [18] .
Comparing the surgical mortality rates from transsphenoidal surgery and transcranial surgery, there was a significant difference in favor of transsphenoidal surgery (1 % vs. 7 %, respectively) [27] .
Long-term survival
The overall survival rates at 1 and 5 years were 95 % and 90 %, respectively. These values were significantly lower than for the control group (adjusted by age, cohort and gender). Older age was the only identified parameter with a significantly increased hazard ratio for shorter survival after surgery.
Patients with hormone-secreting adenomas have an increased long-term mortality rate, and for both somatotrophic and corticotropic adenomas; the standardized mortality rate has been shown to be as high as 3.2 times the rate in the general population [38] . For non-functioning adenomas, the data on long-term survival have been more conflicting, although most studies have reported an increased mortality rate, particularly from cerebrovascular and cardiovascular diseases. A prospective study has shown that hypopituitarism is an independent risk factor for increased mortality, predominantly from vascular and respiratory diseases [41] . Our study included both non-functioning and hormone-secreting adenomas, and the reduced long-term survival in this population is most likely related to the pituitary disease rather than the transsphenoidal surgery.
Limitations and strengths
Although this study is retrospective, the data were retrieved from a prospectively collected database of all tumor surgeries performed at our institution and from a thorough review of medical records. The follow-up regimen was rigid, with all patients controlled at the endocrinology department either at our institution or at the patients' local hospital. Thus, we have follow-up data on all patients with pituitary adenomas treated during the study time period. The data were limited to a single health center (OUH), and all procedures were performed at the OUH-affiliated hospitals Rikshospitalet and Ullevål, thereby reducing the possible confounding effect of variations in access to health care.
Conclusion
We found an overall complication rate of 9.1 % and a low mortality (0.6 %). We did not find a significant difference in the complication rate between the endoscopic and microscopic techniques. The predictors of having a complication were older age, surgery for recurrent tumors, and surgery performed by a low-volume surgeon. The only negative predictor of survival was older age. The overall survival rates at 1 and 5 years were, however, significantly lower for the patients undergoing transsphenoidal surgery than for the control population, most likely because of the pituitary disease.
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